Research Specifications
- Sequence:
- trans-3-hexenoyl-GHRH(1-44)
- CAS:
- 218949-48-5
- Molecular Weight:
- 5135.85 Da
- Vial:
- 20mg lyophilized (2× the 10mg vial)
- Purity:
- ≥98% HPLC verified
Tesamorelin 20mg
Trans-3-hexenoyl-GHRH(1-44)-NH2
CAS: 218949-48-5
−15–18%
VAT reduction at 26 wk
Falutz NEJM 2007
20mg
Bulk vial
~10 days at 2mg label dose
2010
FDA approval
Egrifta label
$179.99In Stock
Buy Now ≥98% Purity Verified Free Shipping $200+ HPLC Tested
Also Known As
TesamorelinEgriftaTH9507trans-3-hexenoyl GHRH(1-44)
Reconstitution & Dosing Guide
BAC Water
4mL
Final Concentration
5 mg/mL
Per Dose
2 mg = 0.4 mL (40 IU) — matches Egrifta clinical label
Daily SC dosing; 20mg vial = ~10 days at label
Often Stacked With
Published References
- 1.Falutz J, Allas S, Blot K, et al.. Metabolic effects of a growth hormone–releasing factor in patients with HIV. NEJM (2007) PMID: 18032764
Research Use Only. This product is intended for in-vitro laboratory research only. Not for human consumption, injection, or therapeutic use. Not medical advice. Always consult applicable regulations in your jurisdiction.
Price Comparison
| Supplier | Purity | Price | Shipping |
|---|---|---|---|
| our verified supplier | >98% HPLC | $179.99 | Free over $200 |
| Generic Research Suppliers | Varies (often <95%) | Similar–Higher | Varies |
| Pharmaceutical (Rx only) | Pharmaceutical grade | Not available for research | Rx required |
Buy Peptides Compounds
Tesamorelin 20mg
$179.99